Jean-François BERGMANN

Jean-François Bergmann, M.D., is Professor of Therapeutics at University Paris VII teaching the methodology of clinical trials and clinical pharmacology and therapeutics. He is the head of the Internal Medicine and Infectious Diseases Department in Hospital Lariboisiere, Paris. This unit takes in charge in-patients with infectious diseases, thrombosis, emergency medicine and internal medicine.
He was a clinical external expert for the EMA. From 2002 to 2012, he was the vice-president of the French AMM (new drugs approval) committee at the French Drug Agency (Afssaps- ANSM). He is the former vice-president of the Transparency Committee (reimbursement committee) (1996-2001). He was the president of the Drugs Committee (COMEDIMS) for the AP-HP (30 public Parisian Hospitals) from 2000 to 2012.
His research topics are the clinical pharmacology of anticoagulants (metabolisms, interactions, use in elderly patients) and the prophylaxis of DVT in medical patients in and out-patients: evaluation of the risk for DVT, therapeutic strategies for an optimisation of the prophylaxis, guide-lines for family doctors. His is also working on clinical pharmacology and therapeutics for metabolic diseases, infectious diseases and hepato-gastroenterology. His research and teaching activities concern therapeutic strategy, drugs development, reimbursement and pricing of new drugs and evaluation of the global benefit/risk ratio of  new drugs in various therapeutic fields.